Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

Article

关键词: ORAL ANTICOAGULATION;    SUBGROUP ANALYSIS;    RISK FACTOR;    STROKE;    TRIAL;    FLUTTER;    RHYTHM;    THROMBOEMBOLISM;    CARDIOVERSION;    PREVALENCE;   

DOI  :  10.1161/CIRCULATIONAHA.113.007825

来源: SCIE

【 摘 要 】

Background-Among patients with implantable pacemakers and defibrillators, subclinical atrial fibrillation (SCAF) is associated with an increased risk of stroke; however, there is limited understanding of their temporal relationship. Methods and Results-The Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT) enrolled 2580 pacemaker and defibrillator patients aged >= 65 years with a history of hypertension but without a history of atrial fibrillation. Pacemakers and implantable cardioverter-defibrillators precisely logged the time and duration of all episodes of SCAF and recorded electrograms that were adjudicated by experts. We examined the temporal relationship between SCAF >6 minutes in duration and stroke or systemic embolism. Of 51 patients who experienced stroke or systemic embolism during follow-up, 26 (51%) had SCAF. In 18 patients (35%), SCAF was detected before stroke or systemic embolism. However, only 4 patients (8%) had SCAF detected within 30 days before stroke or systemic embolism, and only 1 of these 4 patients was experiencing SCAF at the time of the stroke. In the 14 patients with SCAF detected >30 days before stroke or systemic embolism, the most recent episode occurred at a median interval of 339 days (25th to 75th percentile, 211-619) earlier. Eight patients (16%) had SCAF detected only after their stroke, despite continuous monitoring for a median duration of 228 days (25th to 75th percentile, 202-719) before their event. Conclusions-Although SCAF is associated with an increased risk of stroke and embolism, very few patients had SCAF in the month before their event.

【 授权许可】

Free